Skip to main content

Table 2 Antimicrobial susceptibility among 1764 Salmonella enterica isolates from humans with infections in Guangdong province, China, during 2007 and 2012, and MDR in each of the top 11 serovars

From: Serovar distribution, antimicrobial resistance profiles, and PFGE typing of Salmonella enterica strains isolated from 2007–2012 in Guangdong, China

  

No. of isolates resistant to indicated agent at the indicated breakpoint (% resistance)a

 

S. entericaserovar

No. of isolates

AMP Ampicillin

CAZ Ceftazidime

CTX Cefotaxime

FEP Cefepime

NAL Nalidixic acid

CIP Ciprofloxacin

SMX Sulfamethoxazole

TMP Trimethoprim

TCY Tetracycline

GEN Gentamicin

STR Streptomycin

CHL Chloramphenicol

MDR

Enteritidis

257

143(55.64)

11(4.28)

14(5.45)

18(7.01)

212(82.49)

11(4.28)

141(54.86)

23(89.49)

76(29.57)

23(8.95)

110(42.81)

10(3.89)

116(45.14)

Typhimurium

523

453(86.62)

43(82.21)

68(13.01)

69(13.19)

437(83.56)

60(11.47)

455(86.99)

337(64.44)

457(87.38)

340(65.01)

391(74.76)

381(72.85)

454(86.80)

1,4,5,12:i:-

244

220(90.16)

18(7.37)

30(12.29)

29(11.88)

182(74.59)

28(11.47)

220(90.16)

128(52.46)

228(93.44)

141(57.78)

164(67.21)

164(67.21)

218(89.34)

Stanley

167

14(8.38)

10(5.99)

11(6.58)

9(5.39)

19(11.37)

8(4.79)

35(20.96)

14(8.38)

20(11.98)

13(7.78)

25(14.97)

13(7.78)

18(10.78)

Derby

46

15(26.08)

2(4.35)

3(6.52)

3(6.52)

17(36.96)

4(8.69)

35(76.08)

14(30.44)

22(47.83)

14(30.44)

19(41.30)

16(34.78)

15(32.61)

Rissen

36

26(72.22)

3(8.33)

5(13.89)

6(16.67)

5(13.89)

1(2.78)

23(63.89)

30(83.33)

31(86.11)

7(19.44)

16(44.44)

5(13.89)

15(41.67)

Weltevreden

35

3(8.57)

2(5.71)

2(5.71)

2(5.71)

4(11.43)

1(2.86)

8(22.86)

4(11.43)

6(17.14)

3(8.57)

6(17.14)

2(5.71)

3(8.57)

Infantis

28

23(82.14)

0

3(10.71)

2(7.14)

23(82.14)

0

23(82.14)

19(67.86)

19(67.86)

4(14.28)

4(14.28)

21(75)

21(75)

Agona

24

4(16.67)

0

1(4.17)

3(12.5)

4(16.67)

3(12.5)

7(29.17)

3(12.5)

8(33.33)

4(16.67)

5(20.83)

5(20.83)

6(25)

Albany

22

21(95.45)

3(13.63)

4(18.18)

4(18.18)

20(90.9)

1(4.54)

22(100)

20(90.9)

21(95.45)

4(18.18)

7(31.81)

21(95.45)

20(90.9)

Newport

19

3(15.79)

2(10.53)

1(5.26)

0

4(21.05)

1(5.26)

5(26.31)

3(15.79)

6(31.57)

2(10.53)

5(26.31)

3(15.79)

4(21.05)

Typhi

4

1(25)

0

1(25)

0

1(25)

0

1(25)

1(25)

1(25)

1(25)

1(25)

1(25)

1(25)

Paratyphi (A + B + C)

24

5(20.83)

2(8.33)

1(4.16)

1(4.16)

5(20.83)

1(4.16)

4(16.66)

0

2(8.33)

1(4.16)

4(16.66)

0

3(12.5)

Other 114 NTS serovars

335

106(31.64)

28(8.35)

32(9.55)

23(6.86)

119(35.52)

23(6.86)

141(42.09)

106(31.06)

161(31.64)

54(16.11)

121(36.11)

72(21.49)

103(30.74)

Total (% resistance)b

 

1037(58.78)

124(7.03)

176(9.98)

169(9.58)

1052(59.64)

142(8.05)

1120(63.49)

702(39.79)

1058(59.97)

611(34.64)

878(49.77)

714(40.48)

997(56.52)

  1. aThe percentage means the proportion of MDR isolates within each serotype.
  2. bThe percentage means the proportion of MDR isolates in total 1764 isolates.